Cathal Friel

Irish-led firm expects sale of stake in Swedish rare minerals project in ‘near future’

Cathal Friel’s European Green Transition hopes sale will allow it focus on revenue generating opportunities in the green energy transition

Tue Oct 29 2024 - 17:00

European Green Transition begins drilling at rare earth element project in Sweden

Company says results may help it attract a partner for the project

Tue Aug 06 2024 - 17:26

Clinical trials group Hvivo announces departure from Irish stock market

Company says its primary operations, along with the majority of its employees and investor base, are based in the UK

Mon Aug 05 2024 - 15:07

Irish Life has paid €1.73bn in dividends to overseas parent since it was bought from the State a decade ago

The best news, analysis and comment from The Irish Times business desk

Tue Jul 30 2024 - 06:40

Ireland’s Mr IPO and his plans to make more companies public

Cathal Friel shows no sign of slowing down after a busy week which saw him sell his remaining stake in Hvivo

Tue Jul 30 2024 - 05:54

Hvivo chairman Cathal Friel sells remaining shares for €7.3m

Businessman oversaw the initial flotation in 2019 of clinical trials group that became Hvivo

Tue Jul 23 2024 - 16:16

Glandore’s Michael Kelly increases his stake in Poolbeg Pharma

Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel

Sat May 04 2024 - 06:00

European Green Transition takes option on copper remnants from Cypriot mine

Irish entrepreneur Cathal Friel orchestrated the flotation of company earlier this month

Mon Apr 29 2024 - 08:34

Cathal Friel’s green transition firm shares rise in London debut

IPO is fifth put together by Irish serial entrepreneur Cathal Friel in past dozen years

Mon Apr 08 2024 - 09:52

Irish-led green transition firm raises initial €7.6m in London IPO

Funding garnered from institutional investors and family offices

Thu Mar 28 2024 - 17:47

Cathal Friel-chaired green transition firm announces London IPO plan

Friel orchestrated the IPO of Open Orphan in 2019 through the reverse takeover of Dublin-listed Venn Life Sciences

Mon Mar 18 2024 - 07:00

Pharmaceutical services company Hvivo sells almost 30m placing shares

New and existing institutional investors indicated demand for shares was in excess of those available

Wed Feb 14 2024 - 15:40

Open Orphan subsidiary signs deal with global pharma company

Deal will see hVivo manufacture virus for use in human challenge studies

Wed May 04 2022 - 08:29

Investors to buy €1.9m shares in Poolbeg Pharma

Largest individual investor understood to be an experienced life science investor

Mon Apr 11 2022 - 11:30

Open Orphan says Covid infection study may accelerate new vaccines

Shares in Open Orphan were up almost 5% in late morning trading in London

Thu Mar 31 2022 - 12:24

Open Orphan subsidiary signs €6m contract for respiratory study

Company expects revenues from the contract to be recognised across 2022 and 2023

Fri Mar 25 2022 - 07:30

Open Orphan appoints Yamin Khan as new chief executive

Cathal Friel to continue in executive chairman role under new management structure

Thu Feb 24 2022 - 10:24

Potential RSV vaccine achieves regulatory step in US

Bavarian Nordic vaccine candidate used hVivo challenge trial to gather data

Tue Feb 22 2022 - 07:47

‘Human challenge’ Covid trial gives new insight into virus

Open Orphan test shows shorter incubation period, effectiveness of lateral flow tests

Wed Feb 02 2022 - 16:11

Open Orphan subsidiary signs £1.5m contract renewal

Contract to study absorption, distribution, metabolism and excretion of drugs in body

Mon Nov 15 2021 - 09:55

Open Orphan subsidiary signs €6.7m contract for flu study

Influenza could be a major global issue due to low immunity caused by reduced infection

Mon Sept 20 2021 - 08:13

Open Orphan wins €9.5m asthma contract with major pharma company

Study is being carried out under asthma human challenge study model

Tue Aug 24 2021 - 08:51

Open Orphan subsidiary develops human study for malaria

Healthy volunteers are administered a pathogenic or virulent strain of virus

Mon Aug 09 2021 - 07:18

NatWest to take Permanent TSB stake in Ulster Bank loans transfer

Seen & heard: global tax rate above 15%; phasing out leasing of social housing; Poolbeg to seek Nasdaq listing

Sun Jul 18 2021 - 11:41

Open Orphan spin-out Poolbeg to raise £25m in IPO

Infectious diseases specialist to list in London

Wed Jul 14 2021 - 19:31

Open Orphan pharmaceutical company expands Covid-19 trial

Challenge study is providing valuable insight into biology of the virus, firm says

Wed Jul 14 2021 - 07:23

Open Orphan spin-out Poolbeg Pharma to list on London market

Company will use money from listing to meet costs for flu drug trials, develop assets

Thu Jun 17 2021 - 08:03

Open Orphan gets approval to reduce capital ahead of spin-out

Company says reduction of capital will allow it to return value to its shareholders

Wed May 19 2021 - 09:22

Open Orphan plans for possible spin-out of non-core assets

Company says HVO-001 could be included as part of potential demerger

Tue Apr 13 2021 - 16:57

Failure to reform State pension age could cost up to €50bn

Seen and Heard: Quinlan bankruptcy case set for June; Hammerson stuck for Ilac tenants

Sun Mar 28 2021 - 13:03

Open Orphan subsidiary wins €7.5m contract to run study

Contract with US biotechnology company concerns a respiratory syncytial virus

Fri Mar 26 2021 - 07:38

Open Orphan company successfully completes nasal spray study

Prophylactic spray could be used against Covid-19

Wed Dec 23 2020 - 10:56

Open Orphan renews contract with major pharma company

Dublin-listed pharmaceutical services company says new deal will run for another year

Tue Dec 22 2020 - 15:50

Open Orphan gets green light for Covid-19 nasal vaccine trial

Vaccine could be one of the first to provide long-term immunity from Covid-19

Mon Dec 14 2020 - 07:55